Five-membered heterocyclic compounds as inhibitors of SRC family protein kinase.
申请人:Sireen AG
公开号:EP1555264A1
公开(公告)日:2005-07-20
The present invention refers to novel substituted aromatic heteroaryl derivatives of formula (I).
with the definitions of A, L1, L2, G, J, X and Y according to claim 1.
These novel compounds are useful for the inhibition of protein kinases, particularly of the inhibition of Src family protein kinases. Methods for inhibiting kinases by contacting kinases with these novel compounds are disclosed. In another embodiment the present invention refers to pharmaceutical compositions containing these novel compounds and their use for the preparation of medicaments for treating diseases or disorders associated with unphysiological activity of kinases in the body, particularly for the treatment of cancer, immunosuppression, and osteoporosis.
Coupling of thioamides with 4-bromocrotonate esters and subsequent conjugate addition for the rapid one-pot synthesis of functionalized thiazolines
作者:Patrick D. Parker、Yonghe Ge、Joshua G. Pierce
DOI:10.1016/j.tetlet.2017.12.043
日期:2018.1
An efficient one-pot synthesis of functionalized thiazolines via the coupling of thioamides with 4-bromocrotonate esters is described. A range of aryl- and alkyl-thioamides with various substitutions are well-tolerated. Additionally, the presence of the exocyclic ester functionality provides a convenient handle for the synthesis of more complex thiazoline-containing natural products and biologically-relevant
FIVE-MEMBERED HETEROCYCLIC COMPOUNDS AS INHIBITORS OF SRC FAMILY PROTEIN KINASE
申请人:Sirenade Pharmaceuticals AG
公开号:EP1709040A2
公开(公告)日:2006-10-11
[EN] KINASE INHIBITOR COMPOUNDS<br/>[FR] COMPOSES INHIBITEURS DE KINASES
申请人:SIRENADE PHARMACEUTICALS AG
公开号:WO2005068458A2
公开(公告)日:2005-07-28
The present invention refers to novel substituted aromatic heteroaryl derivatives of formula (I), with the definitions of a, L1, L2, G, J, X and Y according to claim 1. These novel compounds are useful for the inhibition of protein kinases, particularly of the inhibition of Src family protein kinases. Methods for inhibiting kinases by contacting kinases with these novel compounds are disclosed. In another embodiment the present invention refers to pharmaceutical compositions containing these novel compounds and their use of medicaments for treating diseases or disorders associated with unphysiological activity of kinases in the body, particularly for the treatment of cancer, immunosuppression, and osteoporosis.
Synthesis of Quaternary-Substituted Thiazolines via Halocyclization of <i>S</i>-Allyl Thioimidate Salts
作者:Patrick D. Parker、Bérénice C. Lemercier、Joshua G. Pierce
DOI:10.1021/acs.joc.7b02299
日期:2018.1.5
described. A range of mono-, di-, and trisubstituted olefins as well as alkyl- and arylthioamides with variations in electronics are tolerated. A rapid anti-diastereoselective halocyclization of these salts provides a variety of substituted alkyl- and arylthiazolines. Initial development of an efficient enantioselective synthesis of quaternary-substituted thiazolines through the organo-catalyzed halocyclization